retatrutide weight loss clinical results Shows 28% in 80 Weeks Retatrutide Phase 3: 60% Achieved

Clinical trials reveal that semaglutide (Wegovy) achieves around 12% weight loss, while tirzepatide (Mounjaro) leads to approximately 18%

Stay current on emerging research

In this article, we explore how Glutathione IV therapy at AustinMD Aesthetics & Wellness can support detoxification, immune function and healthy aging

Retatrutide goes further by engaging additional receptors, potentially offering broader effects for individuals dealing with metabolic challenges

It is important to see a provider/clinic that is well educated on weight loss as a whole, rather than simply prescribing medications, because long-term weight management requires diet, exercise, and lifestyle changes even alongside using weight loss medications

Includes: Ultimate Medication Guide for Patients & Healthcare Professionals & Intuitive Nutrition Guide